European Monitoring Centre for Drugs and Drug Addiction
12
World Health Organisation (WHO)
12
IACAPAP
9
et al.
8
Organización Mundial de la Salud OMS
6
Ministry of Health, Rwanda
5
Organisation Mondiale de la Santé OMS
5
WHO
5
Drugs for Neglected Diseases initiative DNDi
4
Indian Council of Medical Research (ICMR)
4
Ministry of Health and Social Services (MOHSS)
4
Ministry of Health, Kenya
4
OPAS
4
Organisation mondiale de la Santé
4
Organisation Mondiale de la Santé OMS
4
Pan American Health Organisation PAHO
4
Pan American Health Organization
4
Africa CDC
3
C. Carandang
3
C. Gray
3
H. Marval-Ospino
3
United Nations Office on Drugs and Crime
3
Wiedenmayer, K. et al.
3
Africa CDC Centres for Disease Control and Prevention
2
Africa Center for Disease Control and Prevention
2
African Union
2
C. Bachmann
2
Centers for Disease Control and Prevention CDC
2
European Union
2
International Pharmaceutical Federation
2
Ministerio de Salud Argentina
2
Ministerio de Salud Chile
2
Ministerio de Salud Pública y Bienestar Social Paraguay
2
Ministry of Health and Sanitation Sierra Leone
2
Ministry of Health, Gabarone, Botswana
2
National Centre for Disease Control (NCDC)
2
National Vector Borne Disease Control Programme (NVBDCP)
2
Organisation de la Santé Mondiale
2
Organización Mundial de Saude and OPAS
2
Pharmacy Board Sierra Leone
2
Republic of Kenya, Ministry of Health
2
Robert-Koch-Institut RKI
2
S. MacPhee
2
T. Lempp
2
United Nations
2
United Nations Office on Drug and Crime UNODC
2
Zambia Medicines Regulatory Authority (ZAMRA)
2
2012
1
2016
1
A. K. Lam
1
A. Martin
1
A. Smajljaj
1
A. Sondheimer
1
A. Sönnerborg
1
A. Xhuvani
1
A.Ramesh
1
Abdulrahim, D.
1
ACCSI, et al.
1
Adrian Sondheimer
1
Agence Japonaise de Cooperation International Kokusai Kogyo Co., Ltd.
1
Agency for Toxic Substances & Disease Registry
1
AIEPI Hospitalario
1
American Chemistry Council
1
and O. Bowden-Jones
1
ANDEMIA
1
Australian National Clinical Evidence Taskforce
1
Bălă, G.P.
1
Berkley, James A.
1
BioNTech
1
Bolivia, Ministerio de Salud, Gobierno de Estado Plurinacional s
1
Breitner-Busch, S.
1
Bundeszentrale für gesundheitliche Aufklärung
1
Butkus, R. A.
1
Butterworth Heinemann
1
C. Giannou, M. Baldan and A. Molde
1
C. Kalpaki, M. Moudatsou, E. Maraki, et al.
1
Centers for Disease Control and Prevention (CDC)
1
Centre Anti Poison du Maroc
1
Centre d’excellence Africain pour la santé de la Mère et de l’enfant (CEA-SAMEF)
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Chatanga, Peter
1
Chișinău
1
CODEVIDA, Coalición de Organizaciones por el Derecho a la Salud y a la Vida
1
Congressional Research Service
1
Cordner, S.
1
Cureus
1
D. de Lange, D. Radeloff
1
D. Raben
1
D. Radeloff
1
D.de Lange
1
Dadvand, P.
1
Damialis, A.
1
DATER House
1
David P.M., Le Dévédec N. et al.
1
Dermatol Venez, Univerisdad Central de Venezuela
1
Deutsche Hauptstelle für Suchtfragen e.V.
1
Dilys Morgan, Hilary Kirkbride and Bengü Said
1
Directorate General of Health Services Ministry of Health & Family Welfare Government of the People’s Republic of Bangladesh
1
Dr. X. Zeka
1
Drug Safety Monitoring Programme
1
Drugs Advisory Board, Republic of Botswana (Gabarone, Botswana)
1
DTG
1
E. Gjergji
1
E. Subata
1
Elsevier Ltd.
1
EMCDDA
1
Environmental Science and Pollution Research
1
et al
1
Europäische Beobachtungsstelle für Drogen und Drogensucht (EMCDDA)
1
European Centre for Disases Prevention and Control ECDC
1
European Scientific Journal
1
EXPERT REVIEW OF ANTICANCER THERAPY2020, VOL. 20, NO. 4, 271–278
1
F. Fezeu
1
Fairlamb, A.H.
1
Federal Ministries of Agriculture, Environment and Health
1
Food and Agriculture Organization (FAO)
1
Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO)
1
Food and Agriculture Organization of the United Nations FAO
1
Food and Drug Authority (FDA), Ghana
1
Food and Drugs Authority (FDA), Ghana
1
Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA)
1
Frank, A.
1
Frewer, A.
1
Friedman, J.F. et al.
1
Fuller, R.
1
Gascon M., Markevych I.
1
GBD 2019 Blindness and Vision Impairment Collaborators
1
GBD 2019 Tuberculosis Collaborators
1
GBD2019 Dementia Forecasting Coolaborators
1
Global smart
1
Gobierno Bolivariano de Venezuela, UNICEF, et al.
1
Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals
1
Government of Kenya
1
Government of South Africa
1
Government of Tanzania
1
Gutiéerrez, J.
1
Gutiérrez, J.
1
H. Furtmayr, K. Krása
1
Haywood, A. and B. D Glass
1
Health Care without Harm
1
Horn, D.
1
Human Rights Watch
1
ICF International
1
ICRC
1
IFRC
1
Indian Council for Medical Research (ICMR)
1
Indian Council of Medical Research (ICMR) & Department of Biotechnology
1
Instituti Shendetit Public
1
International Bureau for Epilepsy
1
International Committee of the Red Cross ICRC
1
International Dairy Federation
1
International Federation of Medical Students’ Associations (IFMSA)
1
International League against Epilepsy
1
International Pharmaceutical Federation FIP
1
Iosue, S.
1
J Pharm Pharm Sci
1
J. M. Rey. M. Irarrázaval
1
J. O. Errecalde
1
J. Sekulić
1
J.-J. Kim
1
Jackson, J., Kheng Heng, L., Eklund, G. et al.
1
Joseph M Rey
1
Journal of Health Monitoring
1
Kadam. A.
1
Katrin Leitmeyer
1
Kingdom of Swaziland Ministry of Health
1
Koren, H.
1
L'avoisier
1
L. Savikj
1
Laboratorio Central de Salud Publica
1
Liberia Medicines and Health Products Regulatory Authority (LMHRA)
1
Lisa Myers, Laura Theytaz-Bergman
1
M. Hodaj
1
M. Vitoriaa
1
Mapako, Tonderai, Simbarashe Rusakaniko, Maarten J. Postma, Marinus van Hulst, Janet Dzangare, Stellah Ngwende, John Mandisarisa, Ponesai Nyika, David A. Mvere, Owen Mugurungi, and Mufuta Tshimanga
1
Marie-Noel Bruné Drisse and Fiona Goldizen
1
Mario R Dal Poz, Neeru Gupta, Estelle Quain and Agnes LB Soucat
Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе ...с туберкулезом, являлся бысущественным элементом технического сотрудничества ВОЗ с ее государствамичленами. Данная книга, написанная в форме вопросов и ответов, являетсяпервым шагом в этом направлении. Я надеюсь, что она станет доступной длявсех специалистов, участвующих в борьбе с туберкулезом, организаторов здравоохранения и администраторов, ответственных за формирование и выполнение национальных программ борьбы с туберкулезом, а также всех медицинскихработников, ежедневно решающих конкретные задачи борьбы с туберкулезомна местах.more
Данное руководство содержит детальное описание стратегии диагностики и ведения пациентов с лекарственно-устойчивыми формами ТБ, прежде всего с туберкулезом с мн...жественной лекарственной устойчивостью (МЛУ-ТБ). Оно составлено с учетом важных изменений, отмеченных за последние годы, и предназначено для практикующих медицинских работников и программ борьбы с ТБ в странах с умеренными и ограниченными ресурсами.more
The purpose of the WHO Manual for the Public Health Management of Chemical Incidents is to provide a comprehensive overview of the principles and roles of public health in the management of chemical incidents and emergencies. While this information is provided for each phase of the emergency cycle, ...including prevention, planning and preparedness, detection and alert, response and recovery, it is recognized that the management of chemical incidents and emergencies requires a multi-disciplinary and multi-sectoral approach and that the health sector may play an influencing, complementary or a leadership role at various stages of the management process. The target audience includes public health and environmental professionals, as well as any other person involved in the management of chemical incidents.
WHO and all those involved in the development of the publication hope that the publication will have wide application, especially in developing countries and countries with economies in transition, and that in the future the health sector will be better prepared to acknowledge and fulfill its roles and responsibilities in the management of chemical incidents and emergencies, thereby contributing to the prevention and mitigation of their health consequences.
The publication is also available in French: http://apps.who.int/iris/bitstream/handle/10665/246117/9789242598148-fre.pdf?sequence=1 and in Spanish: http://apps.who.int/iris/bitstream/handle/10665/246118/9789243598147-spa.pdf?sequence=1more
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen...ges to health professionals and communities around the world for both human and animal health. These bacteria are not destroyed by the common antimicrobial agents and so pose a risk to people, particularly children, the elderly and those with poorly functioning immune systems, as well as to animals.
Throughout the years, the dairy sector has been very much aware of the need for responsible use and has, in many countries, implemented adequate measures throughout the dairy supply chain.more
Esta “Guía para la elaboración a nivel local de formulaciones recomendadas por la OMS para la desinfección de las manos”, está dividida en dos secciones específicas, relacionadas entre sí
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions of deaths and lost years of healthy life annually. The burden of disease attributable to air pollution is now estimated to be ...on a par with other major global health risks such as unhealthy diet and tobacco smoking, and air pollution is now recognized as the single biggest environmental threat to human health.more
The longlist of knowledge gaps is based on existing research agendas published in 2015 or later and expert input from reviewers of the first draft of the longlist. It only includes knowledge gaps focussing on a better
understanding of the relationship between global environmental change and human h...ealth, and finding an answer to the question of how best to protect human health against these new threats.more
L'application de la technologie de santé numérique se développe rapidement en Afrique, dans
le but d'améliorer la prestation des services de santé et d'atteindre plus efficacement les
communautés éloignées et mal desservies. D'autre part, l'absence de lignes directrices et de
normes da...ns l'ensemble du continent rend difficile le partage des données de manière
significative sur l'ensemble du continent. C'est pourquoi les Centres africains de contrôle et
de prévention des maladies (Africa CDC) ont mis en place un groupe de travail composé de 24
membres afin de fournir une expertise et des conseils pour l'élaboration des lignes directrices
et des normes de l'UA en matière de HIE. Les membres du groupe de travail étaient des
experts en la matière travaillant en Afrique et au niveau international sur la collecte, l'analyse
et l'échange d'informations sur la santé. Certains de ces experts avaient participé à des
consultations antérieures sur la définition de la stratégie des systèmes d'information sur la
santé d'Afrique CDC. Un président, un coprésident et un secrétaire ont été élus pour impliquer
les membres de la tasé force dans différents groupes de travail techniques.more
Conformément aux recommandations de divers comités de l’Organisation mondiale de la Santé (OMS), le Bureau régional de l’OMS pour l’Afrique a mis en place trois initiatives phares afin de permettre aux États Membres de la Région africaine de se préparer aux urgences de santé publique, ...de les détecter et d’y riposter. Ces programmes sont le fruit de consultations approfondies avec plus de 30 Ministres africains, ainsi qu’avec des acteurs techniques, des partenaires à travers le continent et des institutions régionales telles que le Centre africain de contrôle et de prévention des maladies (CDC-Afrique), dont les contributions ont façonné les activités prioritaires. Le présent rapport est le troisième rapport de synthèse trimestriel sur les progrès accomplis dans la mise en œuvre des initiatives phares.more
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.more
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...1 to 784 million by 2045.1 As cases rise, it is imperative to ensure the healthcare workforce is prepared to care for affected individuals. However, there is a growing global shortage of healthcare workers, which was estimated, pre pandemic, to reach 15 million by 2030.2 Therefore, all of the healthcare workforce will need to be utilised to their fullest potential in order to address the growing global burden of diabetes. Pharmacists will continue to be essential in this endeavour.more
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...1 to 784 million by 2045. As cases rise, it is imperative to ensure the healthcare workforce is prepared to care for affected individuals. However, there is a growing global shortage of healthcare workers, which was estimated, pre pandemic, to reach 15 million by 2030. Therefore, all of the healthcare workforce will need to be utilised to their fullest potential in order to address the growing global burden of diabetes. Pharmacists will continue to be essential in this endeavour.more